Yahoo
NasdaqGM - Delayed Quote USD

Sionna Therapeutics, Inc. (SION)

7.18 +0.43 (+6.37%)
At close: September 4 at 4:00:00 PM EDT
7.13 -0.05 (-0.70%)
After hours: September 4 at 7:48:27 PM EDT
Trade SION on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
0
Operating Expense
109,486
88,982
70,556
50,333
41,372
Operating Income
-109,486
-88,982
-70,556
-50,333
-41,372
Net Non Operating Interest Income Expense
12,035
13,295
8,170
2,769
1,132
Other Income Expense
68
419
698
301
--
Pretax Income
-97,383
-75,268
-61,688
-47,263
-40,240
Net Income Common Stockholders
-97,383
-75,268
-61,688
-47,263
-40,240
Diluted NI Available to Com Stockholders
-97,383
-75,268
-61,688
-47,263
-40,240
Basic EPS
-2.15
-1.88
-1.45
-1.70
-2.32
Diluted EPS
-2.15
-1.88
-1.45
-1.70
-2.32
Basic Average Shares
44,912.75
39,962.16
42,444.74
27,797.08
17,332.47
Diluted Average Shares
44,912.75
39,962.16
42,444.74
27,797.08
17,332.47
Total Operating Income as Reported
-109,486
-88,982
-70,556
-50,333
-41,372
Total Expenses
109,486
88,982
70,556
50,333
41,372
Net Income from Continuing & Discontinued Operation
-97,383
-75,268
-61,688
-47,263
-40,240
Normalized Income
-97,383
-75,268
-61,688
-47,263
-40,240
Interest Income
12,035
13,295
8,170
2,769
1,132
Net Interest Income
12,035
13,295
8,170
2,769
1,132
EBIT
-109,486
-88,982
-70,556
-50,333
-41,372
EBITDA
-108,836
-88,335
-69,888
-49,750
-41,250
Reconciled Depreciation
650
647
668
583
122
Net Income from Continuing Operation Net Minority Interest
-97,383
-75,268
-61,688
-47,263
-40,240
Normalized EBITDA
-108,836
-88,335
-69,888
-49,750
-41,250
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 2/7/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: